Statement Of Income And Retained Earnings

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7328356

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
7,647,000,000 JPY
-125,000,000 JPY
-1,216,000,000 JPY
2,499,000,000 JPY
6,500,000,000 JPY
7,717,000,000 JPY
195,000,000 JPY
409,000,000 JPY
5,779,000,000 JPY
658,000,000 JPY
-6,000,000 JPY
6,181,000,000 JPY
-1,073,000,000 JPY
5,108,000,000 JPY
Non-operating income
Non-operating income
6,000,000 JPY
414,000,000 JPY
3,000,000 JPY
433,000,000 JPY
Non-operating expenses
Non-operating expenses
38,000,000 JPY
392,000,000 JPY
58,000,000 JPY
308,000,000 JPY
Ordinary profit (loss)
2,467,000,000 JPY
6,522,000,000 JPY
603,000,000 JPY
5,232,000,000 JPY
Extraordinary income
Extraordinary income
3,340,000,000 JPY
124,000,000 JPY
Profit (loss) before income taxes
2,467,000,000 JPY
9,862,000,000 JPY
603,000,000 JPY
5,357,000,000 JPY
Income taxes - current
3,000,000 JPY
3,514,000,000 JPY
39,000,000 JPY
1,108,000,000 JPY
Income taxes - deferred
-2,000,000 JPY
-1,197,000,000 JPY
-27,000,000 JPY
10,000,000 JPY
Profit (loss)
2,466,000,000 JPY
2,466,000,000 JPY
2,466,000,000 JPY
7,545,000,000 JPY
2,466,000,000 JPY
591,000,000 JPY
591,000,000 JPY
591,000,000 JPY
591,000,000 JPY
4,238,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.